Compounds > 5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine
Page last updated: 2024-09-03

5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine and zonisamide

5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine has been researched along with zonisamide in 1 studies

Compound Research Comparison

Studies
(5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine)		Trials
(5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine)		Recent Studies (post-2010)
(5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine)		Studies
(zonisamide)		Trials
(zonisamide)		Recent Studies (post-2010) (zonisamide)
1001922121382

Protein Interaction Comparison

ProteinTaxonomy5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine (IC50)zonisamide (IC50)
Carbonic anhydrase 12Homo sapiens (human)1.86
Carbonic anhydrase 1Homo sapiens (human)1.86
Carbonic anhydrase 2Homo sapiens (human)1.86
Carbonic anhydrase 2Bos taurus (cattle)1.86
Carbonic anhydrase 3Homo sapiens (human)1.86
Carbonic anhydrase 4Homo sapiens (human)1.86
Carbonic anhydrase 6Homo sapiens (human)1.86
Carbonic anhydrase 5A, mitochondrialHomo sapiens (human)1.86
Carbonic anhydrase 7Homo sapiens (human)1.86
Carbonic anhydrase 9Homo sapiens (human)1.86
Carbonic anhydrase 13Homo sapiens (human)1.86
Carbonic anhydrase 14Homo sapiens (human)1.86
Carbonic anhydrase 5B, mitochondrialHomo sapiens (human)1.86

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anger, T; Madge, DJ; Mulla, M; Riddall, D1

Reviews

1 review(s) available for 5-aminocarbonyl-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5,10-imine and zonisamide

ArticleYear
Medicinal chemistry of neuronal voltage-gated sodium channel blockers.
    Journal of medicinal chemistry, 2001, Jan-18, Volume: 44, Issue:2

    Topics: Amyotrophic Lateral Sclerosis; Analgesics; Anticonvulsants; Epilepsy; Humans; Ion Channel Gating; Models, Molecular; Mutation; Nerve Tissue Proteins; Neuroprotective Agents; Protein Binding; Sodium Channel Blockers; Sodium Channels; Stroke

2001